Kawasaki disease with intravenous immunoglobulin therapy.docVIP

Kawasaki disease with intravenous immunoglobulin therapy.doc

  1. 1、本文档共5页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Kawasaki disease with intravenous immunoglobulin therapy

 PAGE \* MERGEFORMAT 5 Kawasaki disease with intravenous immunoglobulin therapy [Keywords:] Kawasaki disease; intravenous injection; immune globulin Kawasaki disease (Kawasaki disease, KD) the cause is not yet fully understood, although evidence indicates that its incidence may be related to infection, but has not yet been confirmed. Has confirmed the existence of the disease to immune activation of acute phase activation as the main changes in abnormal immune regulation, the main pathological changes of systemic non-specific vasculitis, multiple violations of coronary arteries, some children with the formation of coronary artery aneurysms (Coronary aneurysm, CAA ), in which a small number of children with coronary artery stenosis or thrombosis may occur even lead to myocardial infarction, has therefore become a common acquired heart disease in children. At present there is no disease-specific therapy, the acute phase of treatment aimed at controlling non-specific systemic vascular inflammation and prevent the formation of coronary aneurysms and thrombotic occlusion. Treatment measures and drugs, including: intravenous injection of gamma globulin (intravenous immune globulin, IVIG, or intravenous gamma globulin, IVGG), aspirin (Asprin, ASA), corticosteroids, other treatments, and IVIG treatment of non-responders. Kawasaki disease is now on intravenous immunoglobulin therapy to talk about the following. 1 IVIG treatment of the historical evolution of Kawasaki disease In 1983, Japanese scholars to IVIG treatment of Kawasaki disease was first reported and confirmed that 400 mg / (kg * d), used in conjunction more effective than 5 d less than the total amount of any program [1]. In 1984, Furusho first reported in the Lancet with IVIG plus ASA with ASA treatment alone, compared to more effectively reduce the incidence of coronary artery lesions [2]. Subsequently, in the United States set up a multi-center research group, and carried out two high-dose gamma gl

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档